Lilly and IABL collaborate to supply high-quality affordable insulin in Bangladesh | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Wednesday
July 23, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
WEDNESDAY, JULY 23, 2025
Lilly and IABL collaborate to supply high-quality affordable insulin in Bangladesh

Bangladesh

TBS Report
14 February, 2023, 09:40 am
Last modified: 14 February, 2023, 09:42 am

Related News

  • Type 2 diabetes in young people: Doctor reveals 5 reasons behind this disturbing trend
  • Stem-cell therapies: A breakthrough in treating parkinson's, cancer, diabetes, and more
  • WHO alerts on falsified medicines used for diabetes treatment, weight loss
  • HC orders destroying Pharma Solution's fake diabetes test strips
  • Diabetes camp: 25th BCS cadres, Bangladesh Endocrine Society provide free medical services to 457 patients

Lilly and IABL collaborate to supply high-quality affordable insulin in Bangladesh

TBS Report
14 February, 2023, 09:40 am
Last modified: 14 February, 2023, 09:42 am
Photo :Pixabay
Photo :Pixabay

Eli Lilly and Company (NYSE: LLY) will supply its low-cost active pharmaceutical ingredient (API) for human insulin to International Agencies Bangladesh Ltd. (IABL) to increase patient access and improve affordability for high-quality insulin for nearly one million diabetes patients in Bangladesh by 2030.

IABL will formulate, fill and finish human insulin vials and cartridges under its own trademark and brand name by 2025. The IABL-produced insulin will be exclusively for the Bangladesh market, reports Prnews.

"Lilly is committed to addressing the critical gaps in access to essential medicines for people living with diabetes in low- and middle-income countries," said Ilya Yuffa, president of Lilly International. "Through collaborations like this one with IABL, we are working to reduce barriers to access and ensure ongoing production and uninterrupted supply of insulin so that a greater number of patients can live healthier lives."  

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Addressing the impact of diabetes has been at the heart of Lilly's purpose for more than a century. This is the second recent collaboration aimed at ensuring access to high quality, reduced cost insulin and improving diabetes care across the world. In December 2022, Lilly announced an agreement with EVA Pharma to enhance sustainable access to affordable insulin in 56 low- and middle-income countries, mostly in Africa. Both are part of Lilly's 30x30 initiative, which aims to improve access to quality healthcare for 30 million people living in limited-resource settings, annually, by 2030.

These collaborations are in line with the private sector asks in the World Health Organization's Global Diabetes Compact, a global initiative to support countries in implementing effective programs for the prevention and management of diabetes. Today, people with diabetes can also access more than 150 Lilly patient support programs across 51 countries, reaching close to two million people each year.

"We are very pleased that Lilly has made their world-class insulin crystals available to IABL so that we can manufacture and supply the highest quality insulin to people living with diabetes in Bangladesh," said Mr. Swapan Kumar Modak, managing director and CEO of IABL. "Local manufacturing of human insulins will help meet the insulin demand in Bangladesh and reduce the cost of diabetes treatment and disease complications."

According to the IDF Diabetes Atlas, 13.1 million people are living with diabetes in Bangladesh and this number is expected to increase to about 22.3 million by 2045. Through the Lilly 30x30 initiative, Lilly is active in Bangladesh in additional capacities, including nonprofit collaborations to help improve health outcomes for children and adolescents living with chronic, non-communicable diseases (NCDs), and to provide high-quality diabetes care and treatment for children with type 1 diabetes.

"This agreement has a remarkable potential to reach more patients with locally manufactured human insulins using Lilly's API and augment the company's Lilly 30X30 vision to transform communities and make life better for people around the world," said Vineet Gupta, associate vice president and managing director of Lilly India and alliances. "As a company, Lilly remains committed to delivering breakthrough outcomes for people with diabetes, including in resource-limited settings."

International Agencies (Bangladesh) Ltd. (IABL) group is one of the largest healthcare providers in Bangladesh.

insulin / Eli Lilly & Co / Diabetes

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: CA Press Wing
    Stronger stance needed on maintaining law and order: Political parties to CA
  • Volunteers collect and gather parts of the wrecked plane from the Milestone School and College grounds on Tuesday, a day after the devastating aircraft crash. Photo: Mehedi Hasan/TBS
    Grief, angst and anger: The unbearable toll of Milestone crash
  • Photo: Syed Zakir Hossain/TBS
    Secretariat protest: 75 injured in police-protester clash over edu adviser's resignation for delaying HSC rescheduling

MOST VIEWED

  • Screengrab/Video collected from Facebook
    CCTV footage shows how Air Force jet nosedived after technical malfunction
  • ISPR clarifies crashed plane was battle aircraft, not training jet
    ISPR clarifies crashed plane was battle aircraft, not training jet
  • The jet plane charred after crash on 21 July at the Milestone school premises. Photo: Mehedi Hasan/TBS
    Milestone plane crash: Death toll rises to 31 as nine more succumb to injuries
  • Students and police clash at Milestone School and College on 22 July 2025. Photo: TBS
    Protesting Milestone students clash with police, besiege law and education advisers
  • Photo: Syed Zakir Hossain/TBS
    Secretariat protest: 75 injured in police-protester clash over edu adviser's resignation for delaying HSC rescheduling
  • Aerial view of the Milestone school premises where the crash took place on 21 July. Photo: Olid Ebna Shah/ TBS
    ‘Why here?’: Concerns expressed over airbase inside city

Related News

  • Type 2 diabetes in young people: Doctor reveals 5 reasons behind this disturbing trend
  • Stem-cell therapies: A breakthrough in treating parkinson's, cancer, diabetes, and more
  • WHO alerts on falsified medicines used for diabetes treatment, weight loss
  • HC orders destroying Pharma Solution's fake diabetes test strips
  • Diabetes camp: 25th BCS cadres, Bangladesh Endocrine Society provide free medical services to 457 patients

Features

Photo: Mehedi Hasan/TBS

Aggrieved nation left with questions as citizens rally to help at burn institute

10h | Panorama
Photo: TBS

Mourning turns into outrage as Milestone students seek truth and justice

5h | Panorama
Illustration: TBS

Uttara, Jatrabari, Savar and more: The killing fields that ran red with July martyrs’ blood

1d | Panorama
Despite all the adversities, girls from the hill districts are consistently pushing the boundaries to earn repute and make the nation proud. Photos: TBS

Ghagra: Where dreams rise from dust for Bangladesh women's football

2d | Panorama

More Videos from TBS

What information did the director of the NBPSI give about the admitted patients?

What information did the director of the NBPSI give about the admitted patients?

3h | TBS Today
What is discussed at the Chief Advisor's meeting?

What is discussed at the Chief Advisor's meeting?

3h | TBS Today
Two advisors and press secretary were blocked at Milestone for 8 hours

Two advisors and press secretary were blocked at Milestone for 8 hours

3h | TBS Today
Chief advisor's meeting with 4 parties; what was discussed?

Chief advisor's meeting with 4 parties; what was discussed?

4h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net